ArriVent BioPharma Inc banner

Wall St Price Targets

AVBP Price Forecast
Based on 13 analysts

+112% Upside
from $13.01 today

ArriVent BioPharma Inc (AVBP)’s 12-month stock price forecast through November 2027 has a consensus target of $27.54, implying 112% upside. The forecast is based on price targets from 13 Wall Street analysts.

AVBP Analyst Rating
Based on 11 analysts

avg. 5 of 5
Strong buy
11 100%
Buy
0 0%
Hold
0 0%
Sell
0 0%
Strong sell
0 0%

Analysts rate AVBP Strong buy, with 11 of 11 recommending Buy or Strong buy.

ArriVent BioPharma Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AVBP's stock price target?
Price Target
27.54 USD

According to Wall Street analysts, the average 1-year price target for AVBP is 27.54 USD with a low forecast of 22.22 USD and a high forecast of 31.5 USD.

Back to Top